Literature DB >> 15379294

Cellular and molecular effects of steroid hormones on CNS excitability.

Sheryl S Smith1, Catherine S Woolley.   

Abstract

The steroid hormones 17beta-estradiol (estradiol) and progesterone not only regulate the reproductive system but have other central nervous system effects that can directly affect a variety of behaviors. Generally, estradiol has been shown to have activating effects, including the ability to increase seizure activity, while progesterone has been shown to have depressant effects, including anticonvulsant properties. Because levels of these hormones fluctuate across the menstrual cycle, it is important to understand how changes in these hormone levels may influence levels of excitability in the brain, especially in women who have seizure patterns that are related to their menstrual cycle, a phenomenon known as catamenial epilepsy. This paper reviews the effects of estradiol and progesterone on excitatory and inhibitory neurotransmitters, respectively, and the possible cellular and molecular mechanisms underlying the changes in brain excitability mediated by these hormones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379294     DOI: 10.3949/ccjm.71.suppl_2.s4

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  26 in total

1.  The Perimenstrual Delta Force: A Trojan Horse for Neurosteroid Effects.

Authors:  Aristea S Galanopoulou
Journal:  Epilepsy Curr       Date:  2015 Mar-Apr       Impact factor: 7.500

2.  Changes in hippocampal function of ovariectomized rats after sequential low doses of estradiol to simulate the preovulatory estrogen surge.

Authors:  Helen E Scharfman; Tana M Hintz; Juan Gomez; Kerry A Stormes; Sharon Barouk; Gauri H Malthankar-Phatak; Daniel P McCloskey; Victoria N Luine; Neil J Maclusky
Journal:  Eur J Neurosci       Date:  2007-10-26       Impact factor: 3.386

3.  More is not better: hormones for menopausal women with epilepsy?

Authors:  Page B Pennell
Journal:  Epilepsy Curr       Date:  2007 May-Jun       Impact factor: 7.500

4.  Hormonal contraception is not associated with increased risk for seizures in the general population: results from a cohort study using The Health Improvement Network.

Authors:  Christoph Patrick Beier; Luis A García Rodríguez; María E Sáez; David Gaist; Antonio González-Pérez
Journal:  Eur J Clin Pharmacol       Date:  2018-05-31       Impact factor: 2.953

5.  Progesterone treatment normalizes the levels of cell proliferation and cell death in the dentate gyrus of the hippocampus after traumatic brain injury.

Authors:  Cindy K Barha; Tauheed Ishrat; Jonathan R Epp; Liisa A M Galea; Donald G Stein
Journal:  Exp Neurol       Date:  2011-06-13       Impact factor: 5.330

6.  Effect of sex and ovarian hormones on carotid baroreflex resetting and function during dynamic exercise in humans.

Authors:  Areum Kim; Shekhar H Deo; James P Fisher; Paul J Fadel
Journal:  J Appl Physiol (1985)       Date:  2012-01-19

7.  Adolescent female rats exhibiting activity-based anorexia express elevated levels of GABA(A) receptor α4 and δ subunits at the plasma membrane of hippocampal CA1 spines.

Authors:  Chiye Aoki; Nicole Sabaliauskas; Tara Chowdhury; Jung-Yun Min; Anna Rita Colacino; Kevin Laurino; Nicole C Barbarich-Marsteller
Journal:  Synapse       Date:  2012-02-15       Impact factor: 2.562

8.  Exogenous progesterone exacerbates running response of adolescent female mice to repeated food restriction stress by changing α4-GABAA receptor activity of hippocampal pyramidal cells.

Authors:  G S Wable; Y-W Chen; S Rashid; C Aoki
Journal:  Neuroscience       Date:  2015-09-14       Impact factor: 3.590

9.  The muscle stretch reflex throughout the menstrual cycle.

Authors:  Ellen Casey; Farah Hameed; Yasin Y Dhaher
Journal:  Med Sci Sports Exerc       Date:  2014-03       Impact factor: 5.411

10.  Adolescent female C57BL/6 mice with vulnerability to activity-based anorexia exhibit weak inhibitory input onto hippocampal CA1 pyramidal cells.

Authors:  T G Chowdhury; G S Wable; N A Sabaliauskas; C Aoki
Journal:  Neuroscience       Date:  2013-03-21       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.